Amneal Pharmaceuticals Inc Ordinary Shares - Class A AMRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AMRX is a good fit for your portfolio.
News
-
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray
-
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
-
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
-
Amneal to Report First Quarter 2024 Results on May 3, 2024
-
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
-
Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination
-
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
-
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
Trading Information
- Previous Close Price
- $5.87
- Day Range
- $5.83–5.97
- 52-Week Range
- $1.74–6.46
- Bid/Ask
- $5.86 / $5.95
- Market Cap
- $1.83 Bil
- Volume/Avg
- 1.3 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 6.24
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 7,700
- Website
- https://www.amneal.com
Comparables
Valuation
|
Metric
|
AMRX
|
ASRT
|
600380
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.24 | 1.31 | 16.10 |
Price/Book Value | 90.97 | 0.54 | 1.57 |
Price/Sales | 0.43 | 0.37 | 1.38 |
Price/Cash Flow | 2.63 | 1.13 | 4.86 |
Price/Earnings
AMRX
ASRT
600380
Financial Strength
|
Metric
|
AMRX
|
ASRT
|
600380
|
|---|---|---|---|
Quick Ratio | 0.87 | 1.30 | — |
Current Ratio | 1.63 | 1.83 | — |
Interest Coverage | 0.81 | −85.86 | — |
Quick Ratio
AMRX
ASRT
600380
Profitability
|
Metric
|
AMRX
|
ASRT
|
600380
|
|---|---|---|---|
Return on Assets (Normalized) | 5.40% | −87.36% | — |
Return on Equity (Normalized) | 78.29% | −156.35% | — |
Return on Invested Capital (Normalized) | 12.25% | −128.46% | — |
Return on Assets
AMRX
ASRT
600380
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yygslzsfmr | Csqn | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Ndbxvrvp | Gyyvpr | $70.8 Bil | |
HLN
| Haleon PLC ADR | Prxcfqpb | Dskr | $38.2 Bil | |
VTRS
| Viatris Inc | Ywlfjsthx | Cjbrg | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kgywgcp | Hzgj | $12.5 Bil | |
CTLT
| Catalent Inc | Mpzkpnrt | Hvrzg | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lpbrlhgm | Kwyn | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Xqdbghtng | Txxxj | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fkmpvrtzl | Kwrxy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Ffbdvhslb | Xvbkj | $2.9 Bil |